| 今开：165.66 | 昨收：165.66 |
| 最高：168.455 | 最低：165.045 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：9.301585326E9 |
Repligen(RGEN)03-13 08:25
$雷普里根(RGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-030331 Size: 8 KB 网页链接查看全文
Repligen(RGEN)03-08 05:25
$雷普里根(RGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-027996 Size: 4 KB 网页链接查看全文
Repligen(RGEN)03-05 10:55
$雷普里根(RGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025302 Size: 6 KB 网页链接查看全文
Repligen(RGEN)03-05 10:55
$雷普里根(RGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025296 Size: 7 KB 网页链接查看全文
Repligen(RGEN)03-05 10:55
$雷普里根(RGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025293 Size: 6 KB 网页链接查看全文
Repligen(RGEN)03-01 10:35
$雷普里根(RGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-023495 Size: 7 KB 网页链接查看全文
Repligen(RGEN)03-07 09:15
$雷普里根(RGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-027505 Size: 4 KB 网页链接查看全文
Repligen(RGEN)02-27 09:45
$雷普里根(RGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-020513 Size: 8 KB 网页链接查看全文
Repligen(RGEN)02-28 06:05
$雷普里根(RGEN)$ 144 Report of proposed sale of securities Accession Number: 0001969223-24-000159 Act: 33 Size: 4 KB 网页链接查看全文
Repligen(RGEN)03-19 19:45
$雷普里根(RGEN)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001193125-24-070768 Act: 34 Size: 175 KB 网页链接查看全文
Repligen(RGEN.US)获德银首次覆盖，给予持有评级,目标价180.00美元。 Repligen(RGEN.US)公司简介：Repligen Corp是一家全球性的生命科学公司。它开发和商业化创新的生物加工技术和系统，提高生物药品生产过程的效率和灵活性。该公司的客户包... 网页链接
$Repligen(RGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-041891 Size: 4 KB 网页链接
$Repligen(RGEN)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-083397 Act: 34 Size: 11 MB 网页链接
$Repligen(RGEN)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-083464 Act: 34 Size: 4 MB 网页链接
$Repligen(RGEN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-083416 Act: 34 Size: 149 KB 网页链接
$雷普里根(RGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-034204 Size: 4 KB 网页链接
$雷普里根(RGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-033756 Size: 9 KB 网页链接
$雷普里根(RGEN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-24-033691 Size: 8 KB 网页链接
$雷普里根(RGEN)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001193125-24-070768 Act: 34 Size: 175 KB 网页链接
$雷普里根(RGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-030331 Size: 8 KB 网页链接
$雷普里根(RGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-029523 Size: 21 KB 网页链接